TROG 04.02 - Cervical - FIGO Stage & Tumour Volume - TROG Cancer Research

Read Roland's story about participating in a prostate cancer trial

2026 Clinical Research Education Workshop (CREW) - Virtual attendance now available

Notice of AGM of the Trans Tasman Radiation Oncology Group .

First participant recruited for new lung cancer trial

By w.paterson
15 August, 2021
0 Comments

Prospective Study to Determine the Relationships Between Survival and FIGO Stage, Tumour Volume and Corpus Invasion in Cervical Cancer.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific